ROCKVILLE, Md. , Nov. 2, 2026 /PRNewswire/ — OncoC4, Inc. , a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological diseases, today announced the appointment of Dr. Dan Janiak as Chief Business Officer. Dan brings more than 15 years of. ..
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
RELATED ARTICLES
